Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Healthcare
Biotechnology
2.00 $
-2.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Cadrenal Therapeutics, Inc. Common Stock (CVKD) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 07/21/2026 | Current report (8-K) | Cadrenal Therapeutics, Inc. (CVKD): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report → |
| 07/17/2026 | Current report (8-K) | Cadrenal Therapeutics, Inc. (CVKD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report → |
| 07/10/2026 | Current report (8-K) | Cadrenal Therapeutics, Inc. (CVKD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.